Steroids are used for rheumatoid arthritis because they suppress inflammation fast, often within hours to days, while the primary medications used to treat RA can take up to three months to reach full effect. This speed makes steroids uniquely useful as a short-term tool to control pain and swelling while slower-acting treatments build up in your system. They also play a role in managing sudden flares of symptoms that break through ongoing treatment.
How Steroids Reduce Joint Inflammation
Rheumatoid arthritis is driven by an overactive immune system that attacks the lining of your joints. This attack triggers a cascade of inflammatory signaling molecules, particularly three key ones: TNF-alpha, IL-1 beta, and IL-6. These molecules recruit immune cells to the joint, cause swelling, and gradually erode cartilage and bone if left unchecked.
The steroids used in RA (called glucocorticoids) are synthetic versions of cortisol, a hormone your adrenal glands naturally produce. Cortisol’s job is to dial down inflammation, and it does so by suppressing the release of those same inflammatory molecules. When you take a glucocorticoid like prednisone, you’re essentially flooding your system with a powerful version of that natural brake. The result is a broad, rapid reduction in swelling, pain, and stiffness across affected joints.
This is different from how most RA medications work. Disease-modifying drugs (DMARDs) like methotrexate target the immune dysfunction at its root but take weeks or months to show results. Steroids don’t fix the underlying disease process. They turn down the volume on inflammation quickly, which is why they’re almost always used alongside other treatments rather than on their own.
Bridge Therapy While Other Drugs Kick In
The most common reason steroids are prescribed in early RA is as “bridge therapy.” When you’re first diagnosed and start a DMARD, you may be dealing with significant joint pain and swelling right now, but the DMARD won’t reach its full effect for up to three months. Steroids fill that gap, giving you relief while the longer-term medication builds to therapeutic levels.
European guidelines have recommended this bridging approach since 2013, with the latest revision suggesting steroids be limited to under three months in this role. However, there’s an interesting nuance here: research on the “window of opportunity” in early RA suggests that bridging schedules lasting at least six months have shown long-term beneficial effects that persist even after steroids are stopped. Three months may be too short to capture the full benefit in early disease, which has created some tension between guideline recommendations and clinical evidence.
The 2021 American College of Rheumatology guideline takes a cautious stance, strongly recommending against using steroids for three months or longer alongside DMARDs in newly diagnosed patients. The concern is that the risks of extended use outweigh the benefits for most people, even though some patients clearly do better with a longer course.
Managing Flares
Even with well-controlled RA, flares happen. A flare is a sudden spike in joint pain, swelling, and stiffness that can make daily tasks difficult. Steroids are a go-to option for bringing flares under control quickly.
For systemic flares affecting multiple joints, a short course of oral steroids or an intravenous dose can produce striking, prompt improvement. Research comparing high-dose and low-dose intravenous steroid pulses for RA flares found no significant difference in outcomes, meaning lower doses can be just as effective at calming a flare as the traditional higher doses. This matters because lower doses carry fewer side effects.
When only one or two joints are flaring, a steroid injection directly into the affected joint is often preferred. This delivers a concentrated dose right where it’s needed while minimizing the drug’s effects on the rest of your body. If you’re needing frequent injections in multiple joints, though, that’s typically a sign your overall disease management needs adjusting rather than a problem that more injections can solve.
Low-Dose Maintenance Therapy
Some people with RA end up on a low daily dose of steroids for months or even years, particularly older adults with persistent disease activity despite other treatments. The GLORIA trial, a large placebo-controlled study of patients aged 65 and older with active RA, tested 5 milligrams per day of prednisolone added to standard care for two years. The trial found that this low dose was effective at controlling disease activity and slowing joint damage progression.
The researchers described 5 mg per day as “not particularly dangerous compared with alternatives” over two years, which represents a more pragmatic view than most guidelines take. Still, the ACR guideline is clear: steroid treatment should be limited to the lowest effective dose for the shortest duration possible. The goal is always to use steroids as a temporary measure, not a permanent one, even when reality sometimes looks different.
Risks of Long-Term Use
The reason guidelines push so hard against extended steroid use is the side effect profile. A study of 108 RA patients on prolonged glucocorticoid therapy found that 36% developed high blood pressure, 25% developed osteoporosis, and 20% developed diabetes. Compared to RA patients not on long-term steroids, the risk of diabetes and high blood pressure was roughly four times higher, and the risk of osteoporosis was about two and a half times higher.
These aren’t rare complications at the margins. They’re common outcomes of sustained use, and they compound the cardiovascular risks that RA itself already carries. Other potential effects include weight gain, thinning skin, increased infection susceptibility, mood changes, and cataracts. The higher the dose and the longer the duration, the greater the risk.
This is the core tradeoff with steroids in RA: they work remarkably well and remarkably fast, but the body pays a price for prolonged exposure. That tradeoff is acceptable for short-term bridging or flare management. It becomes harder to justify as months turn into years.
Why Tapering Matters
If you’ve been on steroids for more than a few weeks, you can’t simply stop taking them. Your adrenal glands, which normally produce cortisol on their own, gradually reduce their output when synthetic steroids are doing the job for them. Stopping abruptly leaves your body without enough cortisol to function normally.
Withdrawal symptoms from stopping too quickly include severe fatigue, body aches, joint pain, nausea, lightheadedness, and mood swings. Beyond withdrawal, stopping suddenly can also trigger a rebound flare of your RA symptoms. A gradual dose reduction gives your adrenal glands time to resume normal cortisol production. How long tapering takes depends on how much you’ve been taking and for how long. Full adrenal recovery can range from a week to several months.
Your prescriber will typically reduce the dose in small steps, monitoring for both withdrawal symptoms and returning RA inflammation at each stage. This process requires patience, but it’s one of the most important parts of steroid treatment to get right.